Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy

SIMPLE SUMMARY: Risk stratification via biomarkers used with imaging could support predicting high-risk pancreatic intraductal papillary mucinous neoplasms (IPMN) with malignant potential. We explored the presence of autoreactive antibodies in the blood of patients with IPMN of different grades of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Brindl, Niall, Boekhoff, Henning, Bauer, Andrea S., Gaida, Matthias M., Dang, Hien T., Kaiser, Jörg, Hoheisel, Jörg D., Felix, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332220/
https://www.ncbi.nlm.nih.gov/pubmed/35892825
http://dx.doi.org/10.3390/cancers14153562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332220/
https://www.ncbi.nlm.nih.gov/pubmed/35892825
http://dx.doi.org/10.3390/cancers14153562

Ejemplares similares